Literature DB >> 27474466

A case of desmoid tumor co-existing with recurrent squamous cell carcinoma in the larynx.

Shogo Shinohara1, Atsushi Suehiro2, Masahiro Kikuchi3, Hiroyuki Harada3, Ippei Kishimoto2, Yukihiro Imai4.   

Abstract

Extra-abdominal desmoid tumor, also known as aggressive fibromatosis, has aggressive behavior with local infiltration and tendency for recurrence. Though head and neck is reported to be one of the most common sites, a desmoid tumor in the larynx is extremely rare. A 67-year-old male visited our hospital with prolonged hoarseness and received laryngo-microsurgery with the diagnosis of laryngeal polyp. After the operation, he eventually developed a laryngeal squamous cell carcinoma with papilloma, confirmed by second laryngo-microsurgery and received radiation therapy. After the third laryngo-microsurgery to remove residual papilloma, white irregular mass appeared on the right vocal cord and grew rapidly beneath the glottis, causing dyspnea. After 2 additional laryngo-microsurgeries, he was diagnosed having the dermoid tumor co-existing with recurrent squamous cell carcinoma. He underwent near-total laryngectomy and is currently alive without disease, speaking using a vocal shunt. Only five cases of the desmoid tumors arising in the adult larynx have been reported in the English literature. In this case, repeated surgery and radiation were suspected as the causes. Also, the present report is the first to describe desmoid tumor co-existing with recurrent squamous cell carcinoma in the larynx.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Aggressive fibromatosis; Desmoid tumor; Larynx; Near-total laryngectomy; Squamous cell carcinoma

Mesh:

Year:  2016        PMID: 27474466     DOI: 10.1016/j.anl.2016.07.006

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  1 in total

1.  Case report of recurrent fibromatosis with laryngeal involvement: Treatment based on network analyses of NGS data.

Authors:  Nathan Lloyd; Jonathan Kopel; Sanjay Awasthi; Joehassin Cordero
Journal:  Mol Clin Oncol       Date:  2022-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.